KANG [iKang Healthcare] 6-K: iKang Announces Shareholders’ Approval of “Going Private” Transaction

[iKang Announces Shareholders’ Approval of “Going Private” Transaction Approximately 62.91% of the Company’s total outstanding shares, representing approximately 71.92% of the voting rights of the Company’s shares, voted in person or by proxy at the EGM. If the Merger is completed, the Company will b]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Further Update on “Going Private” Transaction BEIJING, August 15, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that, as of the close of business (]

KANG [iKang Healthcare] 6-K: iKang Announces Further Update on “Going Private” Transaction

[iKang Announces Further Update on “Going Private” Transaction BEIJING, August 15, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that, as of the close of business (]

KANG [iKang Healthcare] 20-F: (Original Filing)

[* Not for trading, but only in connection with the listing on The NASDAQ Global Select Market of American depositary shares. Currently, two ADSs represent one Class A common shares. None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes ]

KANG [iKang Healthcare] 20-F: * Not for trading, but only in connection

[* Not for trading, but only in connection with the listing on The NASDAQ Global Select Market of American depositary shares. Currently, two ADSs represent one Class A common shares. None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes ]

KANG [iKang Healthcare] SC 13E3/A: (Original Filing)

[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]

KANG [iKang Healthcare] SC 13E3/A: Use these links to rapidly review the document

[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal Fourth Quarter and the Fiscal Year 2017 Ended March 31, 2018 BEIJING, JUNE 21, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive health]

Skip to toolbar